Traders Blog - Analysis, Strategies, News and more | Category - Analysis
AbbVie's Big Buy of ImmunoGen Opens Doors for Potential Investment Gains
In some major news dropped on Thursday, AbbVie, the big pharmaceutical player, has announced plans to snatch up ImmunoGen, a drugmaker, for a whopping $10.1 billion. This move is a game-changer for AbbVie, as it brings a promising ovarian cancer drug...
BOJ Holds Steady: Adachi's Cautious Tone Signals Continued Policy
So, things are getting interesting at the Bank of Japan (BOJ). Seiji Adachi, one of the big shots on the board, recently dropped some hints that they're not in a rush to change their super loose money policy. Despite Governor Kazuo Ueda suggesting tw...
Apple's This Strategic Move Drives Continued Profitability and Growth
Apple's latest financial results showed that the company's services business is thriving, with revenue reaching an all-time high of $22.3 billion, up 16% year-over-year. This segment, which includes the App Store, Apple Music, and iCloud, has become...
Reversal trading strategy
Hey there!So, you've heard about the reversal strategy, huh? Well, let me tell you, it's a pretty neat approach that can be quite useful in your trading.Have fun experimenting, and who knows – you might just discover a whole new world of possibilitie...
NVIDIA Shares Hit Record High as Company Prepares to Report Another Quarter of Results
NVIDIA (NASDAQ:NVDA) stock extended its impressive run on Tuesday, closing at a record high of $496.56, up 2.13%. This marks the tenth consecutive trading session in which the stock has gained ground.The surge in NVIDIA`s stock price is being attribu...
Tags
Subscription
